Frontiers in Molecular Neuroscience
Scope & Guideline
Fostering scholarly discourse in the realm of molecular neuroscience.
Introduction
Aims and Scopes
- Molecular Mechanisms in Neurodegeneration:
The journal publishes research exploring the molecular pathways involved in neurodegenerative diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis (ALS), emphasizing the role of proteins, genes, and cellular processes. - Neuroinflammation and Immune Response:
A significant focus is on the role of neuroinflammation in various neurological disorders, examining how immune responses can contribute to disease progression and potential therapeutic targets. - Neurodevelopmental Disorders:
Research articles addressing the genetic and epigenetic factors contributing to neurodevelopmental disorders, such as autism spectrum disorders and intellectual disabilities, are prevalent, highlighting the complex interplay between genetics and environmental influences. - Neural Plasticity and Repair Mechanisms:
The exploration of neuroplasticity, including mechanisms of neuronal repair after injury or disease, is a core area of interest, with studies investigating how neurons adapt and respond to various stimuli. - Biomarkers and Therapeutic Targets:
The journal emphasizes the identification of biomarkers for early diagnosis and monitoring of neurological diseases, along with the exploration of novel therapeutic targets and strategies for treatment. - Cellular and Molecular Signaling Pathways:
Research on various signaling pathways, including Wnt, Notch, and neurotrophin signaling, is a key aspect, exploring their roles in neuronal function, development, and pathophysiology.
Trending and Emerging
- Neuroimmune Interactions:
Research exploring the interactions between the nervous and immune systems is on the rise, with studies investigating how neuroinflammation affects neurological diseases and the potential for immunomodulatory therapies. - Gene Therapy and Genetic Interventions:
There is an increasing focus on gene therapy, including the use of CRISPR technology and viral vectors for the treatment of genetic neurological disorders, reflecting a shift towards innovative therapeutic approaches. - MicroRNAs and Non-Coding RNAs:
The role of microRNAs and other non-coding RNAs in regulating gene expression and their implications in various neurological disorders is gaining attention, highlighting their potential as biomarkers and therapeutic targets. - Neuroplasticity and Rehabilitation:
Emerging research is emphasizing neuroplasticity as a key mechanism in recovery from brain injuries and disorders, with studies focusing on rehabilitation strategies that promote neural repair and functional recovery. - Integration of Omics Technologies:
The integration of genomics, proteomics, and metabolomics in understanding neurological diseases is trending, allowing for a more comprehensive view of the biological mechanisms at play and aiding in the identification of new therapeutic targets. - Environmental and Lifestyle Factors:
A growing body of research is examining how environmental and lifestyle factors, including diet and exercise, impact neurological health, reflecting an increased interest in preventive strategies for brain health.
Declining or Waning
- Traditional Pharmacological Approaches:
There has been a noticeable decrease in publications focusing solely on traditional pharmacological interventions for neurological disorders, as research increasingly shifts towards novel therapeutic strategies, including gene therapy and personalized medicine. - Basic Animal Models:
Research utilizing basic animal models, particularly in preclinical studies, appears to be diminishing in favor of more sophisticated models such as human induced pluripotent stem cells (iPSCs) and organoid systems that better mimic human disease. - Single-Factor Studies:
The emphasis on studies examining single molecular factors or proteins in isolation is declining, with a growing trend towards integrative approaches that consider the complex interactions within cellular and molecular networks. - Focus on Static Biomarkers:
The previous focus on static biomarkers for neurological diseases is waning, as the field moves towards dynamic biomarker identification that can reflect disease progression and therapeutic response more accurately.
Similar Journals
JOURNAL OF CHEMICAL NEUROANATOMY
Exploring the Nexus of Neuroscience and ChemistryJOURNAL OF CHEMICAL NEUROANATOMY, published by Elsevier, focuses on the intersection of neuroscience and chemical processes, making it an essential resource for researchers and professionals in the field. With a commitment to advancing the understanding of the cellular and molecular underpinnings of neuroanatomy, this journal has provided a platform for innovative research since its inception in 1988, with its current dissemination period extending through 2024. Operating from the Netherlands, it has earned its place in the Q3 category of cellular and molecular neuroscience as per the 2023 assessments. While it currently does not offer Open Access options, the journal remains a valuable asset in disseminating cutting-edge studies that explore the complexity of the nervous system. With its ISSN 0891-0618 and E-ISSN 1873-6300, the journal serves a diverse audience, including researchers, clinicians, and students, fostering collaboration and innovation in the ever-evolving field of neuroanatomy.
Acta Neuropathologica Communications
Championing Open Access in Neuropathological Research.Acta Neuropathologica Communications is a distinguished open-access journal published by BMC since 2013, focusing on the rapidly advancing fields of neurology, cellular and molecular neuroscience, and pathology. Located in the United Kingdom, this journal serves as a vital platform for researchers to disseminate significant findings that enhance our understanding of neurological disorders and their underlying mechanisms. With an impressive impact factor reflected in its Q1 ranking across multiple relevant categories, including Cellular and Molecular Neuroscience, Neurology (Clinical), and Pathology and Forensic Medicine, Acta Neuropathologica Communications stands out in the academic community for its rigorous peer-review process and commitment to high-quality research. The journal’s Scopus rankings highlight its global relevance, placing it in the top percentiles among leading research publications. Researchers, professionals, and students alike are encouraged to access and contribute to this essential resource, fostering a collaborative and informed approach to tackling the complexities of neuropathology and neuroscience.
NEUROBIOLOGY OF DISEASE
Transforming Understanding of Neurological DisordersNEUROBIOLOGY OF DISEASE is a premier journal dedicated to advancing the understanding of neurological disorders and the underlying biological processes, published by Academic Press Inc, Elsevier Science. With an impressive impact factor indicative of its significance—ranked in the Q1 quartile in Neurology for 2023 and occupying the 14th rank out of 192 journals in the field of Neuroscience and Neurology—this journal serves as a critical resource for researchers, clinicians, and students alike. The journal has a rich history since its inception in 1994, continuously evolving its scope to encompass groundbreaking research and insights into neurobiological mechanisms and disease pathology. Though it currently does not provide Open Access options, NEUROBIOLOGY OF DISEASE remains a vital vessel for disseminating knowledge that significantly contributes to the field of neurology, fostering an understanding that can lead to innovative therapeutic strategies.
Translational Neurodegeneration
Advancing the Frontiers of Neurodegenerative ResearchTranslational Neurodegeneration, an esteemed journal in the field of neuroscience, is published by BMC and has been an open access platform since 2012, delivering high-quality research from its base in the United Kingdom. With an impressive impact factor reflecting its significant contributions, this journal focuses on critical advancements in cellular and molecular neuroscience, cognitive neuroscience, and clinical neurology, boasting a Q1 ranking across all these categories as of 2023. Researchers and professionals benefit from its extensive reach, characterized by exceptional Scopus rankings that place it in the top percentile of its field. The journal serves as a vital resource for academics and healthcare practitioners alike, aiming to bridge the gap between laboratory discoveries and clinical applications, thereby enhancing understanding and treatment of neurodegenerative diseases. With its commitment to open access, Translational Neurodegeneration ensures that its published research is accessible to a global audience, promoting collaboration and knowledge exchange within the scientific community.
NEUROSCIENCE RESEARCH
Championing High-Quality Neuroscience ResearchNEUROSCIENCE RESEARCH, published by Elsevier Ireland Ltd, is a leading journal in the field of neuroscience, with a notable reputation for disseminating high-quality research that spans a variety of topics within the discipline. With an ISSN of 0168-0102 and an E-ISSN of 1872-8111, this journal serves as a vital platform for both established researchers and emerging voices in the field. Ranking in the Q2 quartile in both Medicine and Neuroscience categories, it has been recognized as a reliable source of innovative findings since its inception in 1984, with continuous publication through 2024. Although it does not currently offer Open Access options, the journal is indexed in Scopus, holding a significant position at Rank #48/113 in General Neuroscience, reflecting its contribution to advancing the understanding of neural mechanisms across various contexts. With its address anchored in Ireland, NEUROSCIENCE RESEARCH plays an essential role in bridging scientific inquiry and practical applications, making it an indispensable resource for researchers, professionals, and students dedicated to the burgeoning field of neuroscience.
Eneurobiologia
Exploring Neural Complexities, One Study at a TimeEneurobiologia is an esteemed open-access journal published by UNIV VERACRUZANA, INST INVESTIGACIONES & EDUCACION, dedicated to advancing research in the vibrant field of neurobiology. With its launch in 2010, the journal aims to disseminate high-quality, peer-reviewed research articles that explore the complexities of neural systems, neurodevelopment, and neurodegenerative disorders. By providing a platform for both established researchers and emerging scholars, Eneurobiologia fosters interdisciplinary collaboration and knowledge exchange within the scientific community. Its open-access model ensures that valuable findings are accessible to a global audience, promoting the widespread application of neurobiological research. As a crucial resource for students, professionals, and researchers alike, Eneurobiologia plays a pivotal role in shaping the future of neurobiological studies and enhancing our understanding of the brain and nervous system.
ACTA NEUROBIOLOGIAE EXPERIMENTALIS
Bridging Research and Clinical Applications in NeuroscienceACTA NEUROBIOLOGIAE EXPERIMENTALIS, an esteemed journal published by the Nencki Institute of Experimental Biology in Poland, has been a pivotal platform for the dissemination of research in the fields of medicine and neuroscience since its inception in 1970. With an ISSN of 0065-1400 and an E-ISSN of 1689-0035, this journal has consistently aimed to contribute to the understanding of neurobiological phenomena, cementing its status within the academic community. Despite its current categorization in the Q3 and Q4 quartiles for Medicine and Neuroscience respectively, ACTA NEUROBIOLOGIAE EXPERIMENTALIS continues to uphold rigorous scientific standards, providing an invaluable resource for researchers, professionals, and students alike. As an essential scholarly outlet, it encourages the exploration of groundbreaking findings and clinical applications in neurobiology, making it an attractive choice for those eager to advance their understanding of this intricate field.
SYNAPSE
Advancing Knowledge, Shaping the Future of NeuroscienceSYNAPSE, an esteemed journal in the field of Cellular and Molecular Neuroscience, is published by Wiley and serves as a vital platform for disseminating groundbreaking research in neuroscience. Established in 1987, this journal has been pivotal in exploring the intricate mechanisms governing synaptic function and neural communication, contributing to our understanding of the nervous system. With an ISSN of 0887-4476 and an E-ISSN of 1098-2396, SYNAPSE is indexed in Scopus and currently holds a Q4 quartile ranking in its category, reflecting its niche yet significant presence within the research community. Despite its recent ranking in the 21st percentile among its peers, the journal’s commitment to quality and innovation remains unwavering. It is published from Hoboken, New Jersey, and although it is not an open-access journal, it provides invaluable insights and critical reviews that are pivotal for researchers, professionals, and students alike who seek to advance their knowledge in the dynamic field of neuroscience. Join us in contributing to the ever-evolving discourse in cellular and molecular neuroscience through SYNAPSE.
CELLULAR AND MOLECULAR NEUROBIOLOGY
Exploring the Nexus of Cell Biology and Neuroscience.CELLULAR AND MOLECULAR NEUROBIOLOGY, published by SPRINGER/PLENUM PUBLISHERS, stands as a significant contributor to the fields of cell biology and neuroscience, holding a distinguished position in the academic community with an impact factor that places it in the Q2 category for both Cell Biology and Cellular and Molecular Neuroscience, along with Q1 in Medicine (miscellaneous). Since its inception in 1981, this journal has provided a critical platform for innovative research and thought-provoking reviews, fostering a deeper understanding of complex neurobiological mechanisms. The journal’s rigorous peer-review process ensures the publication of high-quality manuscripts that offer valuable insights into cellular processes and neural functions. With a commitment to advancing knowledge and promoting collaboration among researchers, CELLULAR AND MOLECULAR NEUROBIOLOGY remains an essential resource for professionals and students alike, looking to stay updated on the latest developments in neurobiology.
CELLULAR & MOLECULAR BIOLOGY LETTERS
Advancing the Frontiers of Cellular and Molecular ScienceCELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.